CRIS Current Research Information System

TAGLIERI, NEVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.152
AS - Asia 8.119
EU - Europa 5.884
AF - Africa 658
SA - Sud America 447
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 24.279
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.997
VN - Vietnam 2.704
SG - Singapore 2.089
CN - Cina 1.688
GB - Regno Unito 1.329
IT - Italia 982
DE - Germania 845
SE - Svezia 721
HK - Hong Kong 535
FR - Francia 387
IN - India 342
BR - Brasile 323
RU - Federazione Russa 295
IE - Irlanda 255
NL - Olanda 247
UA - Ucraina 234
CI - Costa d'Avorio 166
JP - Giappone 145
ZA - Sudafrica 138
TG - Togo 130
FI - Finlandia 123
SC - Seychelles 107
BG - Bulgaria 102
CA - Canada 93
EE - Estonia 93
KR - Corea 92
JO - Giordania 90
BD - Bangladesh 86
NG - Nigeria 77
PH - Filippine 71
CH - Svizzera 62
AR - Argentina 46
BE - Belgio 46
PL - Polonia 40
TH - Thailandia 40
IR - Iran 36
MX - Messico 31
IQ - Iraq 29
TR - Turchia 27
AT - Austria 24
EC - Ecuador 23
ID - Indonesia 22
TW - Taiwan 22
ES - Italia 20
CO - Colombia 17
PK - Pakistan 16
SA - Arabia Saudita 16
CL - Cile 15
UZ - Uzbekistan 15
LT - Lituania 14
RO - Romania 12
JM - Giamaica 11
AU - Australia 10
EG - Egitto 10
HR - Croazia 8
PY - Paraguay 8
GR - Grecia 7
KZ - Kazakistan 6
OM - Oman 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
DK - Danimarca 5
HN - Honduras 5
LB - Libano 5
LV - Lettonia 5
MN - Mongolia 5
MY - Malesia 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
ET - Etiopia 4
PE - Perù 4
PT - Portogallo 4
SN - Senegal 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CR - Costa Rica 3
DZ - Algeria 3
GT - Guatemala 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TN - Tunisia 3
AM - Armenia 2
AZ - Azerbaigian 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CV - Capo Verde 1
Totale 24.253
Salva come PNG Salva come JPEG
Città #
Singapore 1.449
Southend 1.113
Ashburn 1.076
Fairfield 749
Chandler 706
Ho Chi Minh City 627
Hanoi 560
San Jose 541
Hong Kong 509
Santa Clara 411
Woodbridge 362
Houston 354
Wilmington 349
Seattle 328
Ann Arbor 299
Princeton 285
Cambridge 259
Beijing 253
Dublin 252
Boardman 215
Dong Ket 203
Abidjan 166
New York 163
Hefei 160
Bologna 148
Los Angeles 144
Jacksonville 134
Lauterbourg 130
Lomé 130
Westminster 116
Tokyo 114
Nanjing 110
Bremen 108
Padova 108
Turin 104
Berlin 98
Sofia 98
Da Nang 97
Milan 95
Amman 90
Dallas 80
Frankfurt am Main 79
Abeokuta 77
Helsinki 77
Buffalo 71
Haiphong 67
Munich 67
São Paulo 67
Redondo Beach 58
Saint Petersburg 56
San Diego 54
Seoul 54
Council Bluffs 53
Bern 52
Changsha 50
Guangzhou 49
Brussels 45
Shenyang 44
Jinan 43
Johannesburg 40
Medford 40
Shanghai 40
Turku 40
Nanchang 39
Dearborn 38
Hebei 35
The Dalles 34
Biên Hòa 32
London 32
Can Tho 31
Phoenix 31
Yubileyny 30
Toronto 29
Jiaxing 28
Pune 28
Rome 28
Tianjin 28
Falkenstein 27
Mülheim 27
Warsaw 27
Chicago 26
Quận Bình Thạnh 26
Florence 25
Paris 24
Zhengzhou 24
Orem 23
Thái Nguyên 23
Norwalk 22
Atlanta 21
Olalla 21
Shenzhen 21
Mountain View 20
Düsseldorf 19
Ha Long 19
Lanzhou 19
Redmond 19
Washington 19
Falls Church 18
Montreal 18
Nuremberg 18
Totale 15.465
Salva come PNG Salva come JPEG
Nome #
Cystatin C and Cardiovascular Risk 353
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 280
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 267
The role of the vascular surgeon in transcatheter aortic valve implantation 266
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 257
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 248
Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction 247
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 235
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 235
Carbon dioxide coronary angiography: A mechanical feasibility study with a cardiovascular simulator 234
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 231
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 230
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 228
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 224
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 222
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 216
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 213
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 211
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 208
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 206
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 206
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 205
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 203
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 201
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 197
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 197
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 196
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 195
Inferior Q waves in apparently healthy subjects: Should we take a deep breath? An electrocardiographic, echocardiographic and cardiac magnetic resonance study 194
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 194
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 192
[Cystatin C and cardiovascular risk. 191
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 191
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 191
Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease 190
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 188
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 187
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 186
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 186
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 186
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 184
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 183
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 180
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 179
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 179
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction 179
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 179
Cistatina C and rischio cardiovascolare 178
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 177
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 177
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access. 176
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 175
Movement compensation during carbon dioxide coronary angiography: In-vitro validation 174
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 173
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 173
Mid-term and long-term mortality associated with heart failure in patients hospitalized for acute coronary syndromes 172
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 172
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 171
Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes 171
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 170
Peripheral arterial disease and long-term mortality following acute coronary syndromes: insights from a large registry of unselected patients 170
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 170
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 168
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 168
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 168
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 167
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 165
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 163
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 163
A rescue transcatheter solution for early sutureless basal ring infolding 162
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study 162
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 162
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 161
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 161
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 160
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 160
Cystatin C and cardiovascular risk. 159
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 159
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 159
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 159
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 157
Predictors of 32P h brachytherapy failure in patients with high-risk in-stent restenosis 156
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 156
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 155
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 155
Occurrence of major bleeding during long-term follow up of unselected patients with STE vs NSTE Acute Coronary Syndromes 155
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 154
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 154
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 154
Residual aortic regurgitation is a major determinant of late mortality after transcatheter aortic valve implantation 154
Effect of cerebrovascular disease on long-term outcome of patients with acute coronary syndromes: findings from a large cohort of unselected patients 153
Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. 153
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 152
Prognostic significance of mean platelet volume on admission in unselected cohort of patients with non ST-segment elevation acute coronary syndrome 151
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 149
Correlation between aortic root dimension and coronary ectasia 149
Acute hand ischemia after radial intervention in patient with CREST-associated pulmonary hypertension: successful treatment with manual thromboaspiration. 147
Recapture of the Sapien-3 Delivery System After Transversal Balloon Rupture Using a Whole Percutaneous Femoral Approach 147
Coronary ectasia in different scenarios, primarily in myocardial infarction with nonobstructive coronary artery disease 146
Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: The pacing versus no pacing (PNP) study 146
Totale 18.518
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.109
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.491 200 120 145 222 204 120 49 193 85 188 518 447
2022/20233.267 268 458 176 450 268 267 77 179 593 83 281 167
2023/2024985 70 125 49 117 86 309 35 54 21 60 30 29
2024/20253.480 196 484 303 280 532 188 169 103 56 319 130 720
2025/20268.510 1.060 687 601 604 847 406 887 359 1.789 722 299 249
2026/2027123 123 0 0 0 0 0 0 0 0 0 0 0
Totale 24.756